What OCE is and how it works

Optical Coherence Elastography (OCE) is a biomedical imaging modality that combines the high-resolution, depth-resolved imaging of optical coherence tomography (OCT) with the mechanical characterization capabilities of elastography — enabling noninvasive, micron-scale mapping of tissue stiffness and biomechanical properties. At its core, OCE detects nanometer-scale tissue displacements induced by mechanical loading and translates those measurements into quantitative elasticity maps, or elastograms, using phase-sensitive OCT signal processing.

The field encompasses four interrelated sub-domains. Compression OCE (C-OCE) uses controlled external mechanical loading, with displacement detected via phase-sensitive OCT phase shifts — the foundational approach from which the field grew. Dynamic/Wave-based OCE launches propagating elastic waves (shear, Rayleigh, or Lamb waves) through tissue using sinusoidal or impulse excitation; wave propagation speed is then inversely mapped to quantify Young’s modulus, enabling truly quantitative elasticity imaging independent of boundary conditions. Acoustic Radiation Force OCE (ARF-OCE) applies focused ultrasound to create localized, contactless mechanical impulses, making it possible to reach posterior ocular structures and deep soft tissues inaccessible by surface compression. Finally, Passive OCE — exemplified by Heartbeat OCE — exploits physiological motion such as heartbeat pulsation as intrinsic excitation, eliminating external loading devices entirely.

The dataset from which this landscape is derived spans publications from 2009 to 2023, with the majority of core OCE-specific contributions clustered between 2012 and 2022. This analysis represents a snapshot of innovation signals within this dataset only and should not be interpreted as a comprehensive view of the full industry.

Three phases of OCE innovation: 2009–2023

OCE has developed through three discernible phases based on publication dates across the retrieved results, moving from theoretical frameworks to clinical translation attempts over roughly fourteen years.

The Foundational Period (2009–2013) established the technical frameworks for strain estimation, vibration amplitude measurement, and dynamic spectral-domain OCE. The University of Western Australia defined strain sensitivity, signal-to-noise ratio, and dynamic range metrics for phase-sensitive OCE, while Ryerson University’s 2013 Digital Image Correlation–Based OCE work established sub-micron displacement resolution using DIC algorithms integrated with OCT.

The Technical Maturation Period (2014–2019) saw OCE applied to specific tissue targets — particularly the eye — with multi-physics modelling, quantitative fiber-optic probes, and acoustic radiation force approaches emerging. Columbia University Medical Center’s 2018 in vivo ARF-OCE study in rabbit models represented a landmark translation milestone, while the University of Houston’s 2017 Applanation OCE demonstrated non-contact intraocular pressure and corneal biomechanics measurement with a single instrument.

The Clinical Translation and System Miniaturization Period (2020–2023) reflects the field’s most recent trajectory: portable instruments, passive excitation methods, and real-time signal processing. The Max Planck Institute for the Science of Light’s 2021 portable OCE system with a common-path flexible fiber probe reduces phase noise by an order of magnitude over standard systems. Real-time processing was demonstrated using computationally efficient vector methods for compression OCE by the Russian Academy of Sciences, also in 2021.

Four core technology clusters shaping OCE research

OCE innovation organises into four distinct technical clusters, each defined by its excitation mechanism and signal reconstruction approach — and each carrying different implications for clinical translation readiness.

Cluster 1: Phase-Sensitive Compression OCE

The most established OCE modality uses controlled compressive loading and phase-sensitive detection of inter-frame OCT phase shifts to compute local axial strain gradients. The University of Western Australia’s 2012 strain estimation work demonstrated approximately 12 dB improvement in signal-to-noise ratio using weighted least squares strain estimation — a result that underpins the field’s strain sensitivity benchmarks. The Russian Academy of Sciences’ 2021 vector method enabled real-time elastographic mapping of Young’s modulus, achieving the computational efficiency necessary for clinical use. Most recently, the University of Vienna’s 2023 comparative study addressed precision and reproducibility deficits in quantitative Young’s modulus estimation across three reconstruction methods — a direct response to the clinical deployment barrier.

Cluster 2: Dynamic Wave-Based OCE

Wave-based OCE launches propagating elastic waves through tissue and maps wave propagation speed to tissue stiffness. According to WIPO patent classification frameworks, wave-propagation methods in medical imaging represent one of the most active areas of ultrasound and optical imaging IP. In OCE specifically, the University of Washington’s 2015 shear wave study introduced pulse compression acoustic radiation force for safe ophthalmic shear wave excitation, minimising ultrasound pressure exposure. The same group’s 2019 spatial resolution characterisation identified mode-conversion effects at tissue boundaries as the fundamental limit on lateral spatial resolution in wave-based OCE — a finding with direct implications for system design.

Cluster 3: Acoustic Radiation Force OCE

ARF-OCE uses focused ultrasound to apply localised, contactless mechanical impulses to tissue, enabling OCE of posterior ocular structures and deep soft tissues inaccessible by surface compression. Columbia University Medical Center’s 2018 in vivo study was the first to map retinal layer elasticity in rabbit models, identifying layer-specific stiffness gradients from 3 to 16 kPa. The Beckman Laser Institute at the University of California, Irvine extended ARF-OCE in 2019 to simultaneously assess both the cornea and crystalline lens in vivo using a swept-source system — directly relevant to presbyopia and cataract biomechanics.

Cluster 4: Passive and Multi-Modal OCE

The most recent cluster addresses the elimination of external excitation (passive OCE) and the combination of OCE with complementary optical contrasts for enhanced tissue discrimination. The University of Houston’s Heartbeat OCE work (2020–2021) demonstrated passive OCE using heartbeat-induced corneal deformation, successfully distinguishing untreated and UV-A crosslinked corneas — first ex vivo, then in vivo in rabbit corneas — without any external mechanical actuator. The University of Tsukuba’s Polarization-Sensitive OCE (2019) integrated Jones matrix PS-OCT with compression OCE to simultaneously map OCT intensity, attenuation, birefringence, and microstructural deformation in porcine aorta and esophagus.

“Heartbeat OCE eliminates the need for any external mechanical actuator — successfully distinguishing crosslinked from untreated corneal tissue in vivo using only the patient’s own heartbeat pulsation as mechanical excitation.”

Application domains: ophthalmology leads, others emerge

Ophthalmology is the overwhelming dominant application domain for OCE in this dataset, with multiple converging application threads that together represent the most mature OCE market vertical. Beyond the eye, dermatology, oncology, orthopedics, and cardiovascular imaging each represent earlier-stage but strategically significant opportunities.

Ophthalmology

Four distinct ophthalmic applications are represented across the dataset. Corneal biomechanics and crosslinking monitoring is addressed by multiple groups including the University of Houston and Wenzhou Medical University — the latter demonstrating OCE discrimination of three corneal crosslinking irradiance protocols in vivo (2019), directly relevant to keratoconus management. Intraocular pressure and glaucoma assessment is addressed by the University of Houston’s Applanation OCE (2017) and the University of Southern California’s Lamb wave model-based optic nerve head biomechanics study (2019). Retinal elasticity and age-related macular degeneration is targeted by ARF-OCE studies from Columbia University and synchronized ARF-OCE work (both 2018), with AMD cited as a primary clinical motivation. Crystalline lens and presbyopia assessment is addressed by the Beckman Laser Institute’s 2019 simultaneous cornea-lens ARF-OCE study.

Dermatology, Oncology, and Musculoskeletal

The University of Western Australia’s 2011 in vivo 3D-OCE work on human skin established skin as an accessible test bed for OCE system development, demonstrating hydration-dependent stratum corneum elasticity. In oncology, dynamic spectral-domain OCE was applied to rat tumor tissue ex vivo, with Harvard Medical School researchers noting OCE’s potential for malignancy and coronary artery disease diagnostics. Fiber-optic quantitative OCE probes from New Jersey Institute of Technology address in situ tumor margin characterization.

For musculoskeletal applications, Brigham and Women’s Hospital’s 2022 minimally invasive PS-OCT catheter for pre-osteoarthritis assessment — published in Nature-indexed literature — represents an emerging orthopedic OCE application using a minimally invasive endocatheter configuration. The cardiovascular track, referenced by Harvard Medical School and the Cardiovascular Research Foundation at Columbia University, addresses plaque cap stress and strain quantification using combined IVUS-OCT imaging as a methodology parallel to OCE.

Geographic and institutional landscape

The United States dominates OCE innovation in this dataset, with Australia contributing foundational methodology and Germany, Japan, Russia, China, and Austria each contributing distinct technical threads. The institutional concentration is notable: a relatively small number of academic groups account for the majority of core OCE advances.

The United States leads with multiple groups — University of Houston, University of Washington, UC Irvine, New Jersey Institute of Technology, Columbia University, Harvard Medical School, and University of Southern California — each contributing distinct technical threads. Australia’s University of Western Australia established the foundational compression OCE methodology that the field built upon. Germany (Max Planck Institute), Japan (University of Tsukuba), Russia (Russian Academy of Sciences), Austria (University of Vienna), and Italy (Sapienza University of Rome) each contribute important but narrower technical contributions.

A strategically significant observation is the increasing volume of contributions from Chinese academic institutions. Wenzhou Medical University, Tianjin University, and Sun Yat-sen University-affiliated groups are publishing increasingly sophisticated OCE results in the 2019–2022 window. As noted by OECD science and technology outlook reports, China’s share of high-impact biomedical engineering publications has grown substantially over the past decade, and the OCE dataset reflects this broader trend. Technology investors and IP strategists should monitor CN-jurisdiction filings in wave-based and in vivo corneal OCE as this activity matures into commercial products.

Emerging directions and strategic implications for 2026

Six forward-looking directions are evident from the most recent filings and publications (2020–2023) in this dataset, each with distinct implications for R&D investment, IP strategy, and clinical development priorities.

1. Passive excitation (Heartbeat OCE) as a clinical simplification pathway

The University of Houston’s 2020 and 2021 Heartbeat OCE publications represent a fundamental departure from requiring actuators, making the technique inherently patient-friendly and potentially clinic-ready. This direction eliminates a major hardware complexity barrier. From an IP standpoint, this approach is currently underdeveloped relative to its clinical potential — early movers in portable passive OCE system patents could establish strong positions.

2. Portable and flexible probe systems for non-ophthalmic markets

The Max Planck Institute’s 2021 portable OCE system with a common-path flexible fiber probe enables multi-site body access beyond the anterior eye. Combined with Brigham and Women’s Hospital’s 2022 minimally invasive PS-OCT catheter for pre-osteoarthritis assessment, form-factor innovation — not just optical or signal-processing advances — is emerging as a viable competitive differentiator for orthopedic and gastroenterological markets. As standards bodies including ISO develop frameworks for optical medical device safety, portable OCE systems will need to demonstrate compliance pathways alongside clinical validation.

3. Real-time quantitative elastography

The Russian Academy of Sciences’ vector method for real-time strain and Young’s modulus mapping (2021) directly addresses the processing speed deficit that has limited OCE to post-acquisition analysis. Real-time capability is not merely a convenience feature — it is a prerequisite for intraoperative use and dynamic tissue assessment during interventional procedures.

4. Multi-parametric and polarization-integrated OCE

The integration of birefringence, attenuation coefficient, and mechanical deformation within a single PS-OCE acquisition (University of Tsukuba, 2019) anticipates multi-contrast tissue classification systems. Similarly, Sapienza University’s 2017 multi-channel shear wave OCE enables 3D elasticity mapping with relative and absolute wave timing. These multi-parametric approaches align with the broader push in precision diagnostics — documented across NIH-funded research programs — toward tissue characterization that combines structural, functional, and mechanical contrast in a single acquisition.

5. Quantitative reconstruction rigor for regulatory approval

The University of Vienna’s 2023 comparative study of inversion methods for quantitative Young’s modulus estimation signals the field’s maturation toward regulatory-grade reproducibility. This is a prerequisite for clinical device approval. R&D teams should prioritize regulatory-compliant quantitative reconstruction methods and reproducibility validation on tissue phantoms alongside system hardware development.

6. 3D full-field strain tensor quantification

Tianjin University’s 2022 image quality assessment framework for DVC-based OCE addresses the challenge of reliable 3D full-strain-tensor quantification, extending OCE from single-axis strain estimates to complete mechanical characterization. This direction is particularly relevant for cartilage and musculoskeletal tissue assessment where anisotropic mechanical behaviour dominates.

“The ophthalmic application domain is contested by multiple US academic groups — Houston, Washington, UC Irvine, Columbia — with overlapping claims around excitation method, wave model, and anatomical target. Freedom-to-operate analysis is warranted before commercial development.”